Printer Friendly

Browse Respiratory agents topic

 

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
Asthma and COPD Market Set to Grow Leading to Surge in Demand for Combination Inhalers for Upper Airway Diseases. Aug 25, 2015 671
Asthma and COPD Market Set to Grow Leading to Surge in Demand for Combination Inhalers for Upper Airway Diseases. Aug 25, 2015 631
Drugs for respiratory system treatment. Aug 12, 2015 145
Asthma Treatment Drugs Markets in China. Aug 5, 2015 419
Lung Cancer Treatment Drugs Markets in China. Aug 5, 2015 420
Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF). Jul 6, 2015 944
Annual Repair work for Painting, Distempering, White Washing in Pulmonary Medicine Centre at Jehangirabad, Bhopal for the one year. Jul 6, 2015 135
Atopix Therapeutics Secures Funding to Broaden Development of CRTH2 Antagonists for TH2-Mediated Disease. Jun 17, 2015 1027
Atopix Therapeutics Secures Funding to Broaden Development of CRTH2 Antagonists for TH2-Mediated Disease. Jun 17, 2015 1033
Asthma sufferers 'being put at risk' warns charity. Jun 16, 2015 294
Warning over asthma inhaler prescriptions. Jun 16, 2015 609
Pulmatrix and Mylan Enter Into ex-U.S. Development Agreement for PUR0200. Jun 16, 2015 1067
Global Pediatric Drugs and Vaccines Market. Jun 10, 2015 7412
Nebulizers, Inhalers and Respirators for Asthma Treatment: Global Markets. Jun 8, 2015 534
Steroid injections don't help in asthma, says Omani doctor. Jun 6, 2015 277
Frontier Pharma: Asthma - Identifying and Commercializing First-in-Class Innovation 2015: Market Landscape to Grow in Diversity over Coming Years. Jun 4, 2015 780
Frontier Pharma: Asthma - Identifying and Commercializing First-in-Class Innovation 2015: Market Landscape to Grow in Diversity over Coming Years. Jun 4, 2015 786
Syp. antitussive. Jun 2, 2015 117
New Therapies to Enhance Increasingly Competitive Non-Small Cell Lung Cancer Treatment Market. Jun 1, 2015 735
New Therapies to Enhance Increasingly Competitive Non-Small Cell Lung Cancer Treatment Market. Jun 1, 2015 740
Personalized Treatment for Severe Asthma to Drive Market Growth Despite Patent Expirations. May 29, 2015 753
Personalized Treatment for Severe Asthma to Drive Market Growth Despite Patent Expirations. May 29, 2015 758
FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD. May 26, 2015 3964
Novartis investigational dual bronchodilator significantly improved lung function compared to single bronchodilators in patients with moderate-to-severe COPD in phase III studies. May 20, 2015 3196
Inhaled Drug Delivery to 2022 : Drugs, Devices, Markets and Forecasts. May 19, 2015 456
Orally Inhaled Bronchodilators to 2022. May 19, 2015 338
Regeneron and Sanofi Announce Positive Pivotal Phase 2b Dupilumab Data in Asthma Presented at the American Thoracic Society 2015 International Conference. Conference news May 18, 2015 2406
Supply of Ophthalmology Norvmydriatic Retinal Camera & Analysis System ,Ophthalmology Portable Auto refractometer,Ophthalmology Trabeculoplasty Laser,Pulmonary Medicine Portable Spirometry System,Pulm. May 15, 2015 124
Elsevier Presents the Sixth Edition of Murray & Nadel's Textbook of Respiratory Medicine at 2015 American Thoracic Society Conference. May 15, 2015 892
Elsevier Presents the Sixth Edition of Murray & Nadel's Textbook of Respiratory Medicine at 2015 American Thoracic Society Conference. May 15, 2015 896
Cuba launches revolutionary drug to treat lung cancer; US in deal to turn it into vaccine. May 13, 2015 353
Cuba launches revolutionary drug to treat lung cancer; US in deal to turn it into vaccine. May 13, 2015 348
Merck Receives FDA Fast Track Designation for Evofosfamide for Treatment of Patients Living With Advanced Pancreatic Cancer. May 12, 2015 1388
Merck KGaA, Darmstadt, Germany, Receives FDA Fast Track Designation for Evofosfamide for the Treatment of Patients Living With Advanced Pancreatic Cancer. May 12, 2015 1432
EMA Releases Draft Opinion on Two Patient-Reported Outcome (PRO) Measures for Evaluating New Treatments for COPD. May 11, 2015 542
EMA Releases Draft Opinion on Two Patient-Reported Outcome (PRO) Measures for Evaluating New Treatments for COPD. May 11, 2015 567
Spyryx Biosciences Secures $18 Million in Series A Financing. May 7, 2015 780
The supply of medical equipment for the sub-carpathian lung diseases centre in rzeszEw as part of the program titled mz. "improving standards of surgical treatment and lung cancer combined - retrofitt. May 6, 2015 162
FDA approves BREO ELLIPTA for the treatment of adults with asthma in the US. Apr 30, 2015 2948
Majority of lung cancer treatment decisions are not guided by patient's genetic makeup, according to new international survey. Apr 22, 2015 1249
People with diabetes should know that... cough medicine could help. Apr 21, 2015 149
DelMar Pharmaceuticals Presents Positive Preclinical Data on VAL-083 for Treatment of Non-Small Cell Lung Cancer at the American Association of Cancer Research Annual Meeting. Apr 19, 2015 1839
Panel backs ICS/LABA combo for asthma in adults. Mechcatie, Elizabeth Apr 15, 2015 904
Nebulizers, Inhalers and Respirators for Asthma Treatment: Global Markets. Apr 14, 2015 540
Global Orally Inhaled Corticosteroids Market Report 2015-2022. Apr 9, 2015 524
Global Orally Inhaled Bronchodilators Market to 2022. Apr 9, 2015 653
Global Orally Inhaled Corticosteroids Market Report 2015-2022. Apr 9, 2015 551
Global Orally Inhaled Bronchodilators Market to 2022. Apr 9, 2015 680
DelMar Pharmaceuticals Announces Panel Participation in Cancer Advance Boston Conference on April 14, 2015. Conference news Apr 7, 2015 949
Alexander Chi, MD Involved in Groundbreaking Lung Cancer Treatment Studies. Mar 27, 2015 486
Egalet Provides Commercial Update on SPRIX and OXAYDO(TM). Mar 25, 2015 2038
Selten Pharma, Inc. Receives Orphan Drug Designation From U.S. FDA for the Treatment of Pulmonary Arterial Hypertension. Mar 18, 2015 771
LUNGevity Foundation Celebrates Women Making History in Science. Mar 10, 2015 930
Syp. antitussive. Mar 3, 2015 117
DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083. Mar 2, 2015 1047
Novel vaccines effective against poultry diseases. Avant, Sandra Mar 1, 2015 473
Vitamin D3 and asthma. Mar 1, 2015 582
Supply of various medicinal products including antibacterial agents that reduce blood clotting, for the treatment of respiratory, vaccines, mineral additives, immunoglobulin products to treat nervous. Feb 27, 2015 356
Launch of Turing Pharmaceuticals Announced - New Drug Company to Focus on Treating Unmet Medical Needs Across Broad Therapeutic Areas. Feb 24, 2015 894
Cardiovascular and Respiratory Medicines. Feb 24, 2015 177
New Phase III Data in Asthma Patients Show Tiotropium Improves Lung Function, Regardless of Allergic Status. Feb 21, 2015 1714
Cardiovascular and Respiratory Medicines. Feb 20, 2015 181
United Kingdom : GSK and Theravance announce start of phase III lung function study with closed triple combination treatment FF/UMEC/VI for COPD. Report Feb 10, 2015 366
University Of Maryland Medicine Announces New National Program In Lung Healing To Develop Innovative Approaches For Preventing And Treating Acute Lung Disease. Feb 6, 2015 2544
United States : Mylan shoulders way into blockbuster market for COPD treatments. Feb 4, 2015 145
FDA panel rejects oral desmopressin for nocturia. Mechcatie, Elizabeth Feb 1, 2015 977
Serendex Pharmaceuticals And CMC Biologics Enter Exclusive Agreement On Factor VIIa. Jan 30, 2015 748
Serendex Pharmaceuticals And CMC Biologics Enter Exclusive Agreement On Factor VIIa. Jan 30, 2015 717
Xencor Reports XmAb7195 Top-line Interim Phase 1a Results Showing Rapid Reduction of Serum IgE in Healthy Volunteers. Jan 29, 2015 2025
U.S. FDA Approves IMBRUVICA (ibrutinib) for Treatment of Waldenstrom's macroglobulinemia (WM). Jan 29, 2015 2959
U.S. FDA Approves IMBRUVICA (ibrutinib) for the Treatment of Waldenstrom's Macroglobulinemia: First FDA-Approved Therapy for This Disease. Jan 29, 2015 2263
Tender document for rate contract for supply and installation of diffusion system, spirometer, thoracoscopy system and ebus at pulmonary medicine department at aiims bhopal. Jan 28, 2015 113
GSK expands its portfolio of medicines in the US for patients with asthma and COPD. Jan 26, 2015 1837
SPIRIVA RESPIMAT (tiotropium bromide) Inhalation Spray Now Available in the United States. Jan 21, 2015 1662
Cough suppressant may ease fibromyalgia pain. Jan 9, 2015 449
U.S. FDA Approves Daiichi Sankyo's Once-Daily SAVAYSA(TM) (edoxaban) Tablets for Reduction of Stroke Risk in Non-Valvular Atrial Fibrillation and for the Treatment of Venous Thromboembolism. Jan 8, 2015 4096
Inhaled COPD Therapeutics. Dec 12, 2014 598
Inhaled Asthma Therapeutics. Dec 12, 2014 611
Inhaled CNS Therapeutics. Dec 12, 2014 685
Inhaled COPD Therapeutics. Dec 12, 2014 625
Inhaled Asthma Therapeutics. Dec 12, 2014 638
Inhaled CNS Therapeutics. Dec 12, 2014 712
Dry Powder Inhalers to 2020. Dec 12, 2014 677
Dry Powder Inhalers to 2020. Dec 12, 2014 683
Apellis Pharmaceuticals Raises $33M to Fund its Complement Immunotherapy Programs. Dec 2, 2014 1111
Global Pulmonary Drug Delivery Systems Market 2015-2019: Key Vendors are AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Novartis and Philips Healthcare. Dec 2, 2014 780
Global Pulmonary Drug Delivery Systems Market 2015-2019: Key Vendors are AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Novartis and Philips Healthcare. Dec 2, 2014 809
Antemortem diagnosis and successful treatment of pulmonary candidiasis in a sun conure (Aratinga solstitialis). Proenca, Laila M.; Mayer, Jorg; Schnellbacher, Rodney; Sanchez, Susan; Huang, Chien-Tsun; Brown, Hol Report Dec 1, 2014 2508
Asthma Treatment Market (Drug) Worth $23 Billion by 2023. Nov 28, 2014 1464
Asthma Treatment Market (Drug) Worth $23 Billion by 2023. Nov 28, 2014 1468
Online Marketing Will Be a Boon for the Global Pulmonary Drug Delivery Systems Market From 2015 to 2019. Nov 18, 2014 874
Online Marketing Will Be a Boon for the Global Pulmonary Drug Delivery Systems Market From 2015 to 2019. Nov 18, 2014 880
LAMA/LABA topped fluticasone/salmeterol in COPD. Worcester, Sharon Nov 15, 2014 690
A Competitive Analysis of the Global Asthma and COPD Therapeutics Market. Nov 12, 2014 457
A Competitive Analysis of the Global Asthma and COPD Therapeutics Market. Nov 12, 2014 463
A Competitive Analysis of the Global Asthma and COPD Therapeutics Market : Novel Inhaler Devices and Formulations are Impetuses for Growth. Nov 10, 2014 624
Germany : Boehringer Ingelheim announces U.S. FDA filing acceptance of NDA for Spiriva Respimat in asthma. Nov 5, 2014 170
Boehringer Ingelheim Announces U.S. Filing Acceptance of New Drug Application for Spiriva Respimat (tiotropium bromide) Inhalation Spray for the Treatment of Asthma. Nov 3, 2014 2068
Celsion Presents Preclinical Data for its TheraSilence(TM) Platform at the miRNA World Conference Workshop on miRNA Delivery. Conference news Oct 29, 2014 979
Boehringer Ingelheim Presents Data for the Co-Administration of Two Approved Products for COPD Patients. Oct 27, 2014 2477
Global Pediatric Drugs and Vaccines Market. Oct 23, 2014 6077
Buy cough medicine? Don't waste your money, honey; Home-made remedy just as effective, say docs. Oct 16, 2014 140
In the Face of Sales Erosion of Key Brands by Novel Formulations, GlaxoSmithKline/Theravance's LABA/LAMA Anoro Will Become the Leading COPD Agent in 2023. Drug overview Oct 15, 2014 682
Pulmonary Drug Delivery Systems: Technologies and Global Markets 2014. Oct 14, 2014 1050
Support for Healthcare Professionals in Tackling the Burden of Symptomatic Asthma. Oct 8, 2014 689
New COPD Maintenance Treatment Striverdi Respimat (olodaterol) Inhalation Spray Now Available in U.S. Pharmacies. Oct 8, 2014 1565
DelMar Pharmaceuticals Announces Presentations at Upcoming Scientific Meetings. Oct 6, 2014 510
Common Medications for Lung Diseases Hospital Leon Daniello Cluj-Napoca. Oct 5, 2014 441
Lightlake Therapeutics Inc. Announces Closing Of Investments In Two Products. Oct 2, 2014 917
Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps. Sep 30, 2014 2056
ASCO 2014 -- Delegate Physicians Rate Influence and Impact. Sep 30, 2014 1057
PharmaPoint: Asthma - Japan Drug Forecast and Market Analysis to 2023. Sep 30, 2014 562
CytRx Receives Multiple FDA Orphan Drug Designations for Aldoxorubicin for the Treatment of Glioblastoma, Small Cell Lung Cancer and Ovarian Cancer. Sep 29, 2014 1507
Boehringer Ingelheim Announces FDA Approval of Spiriva Respimat (tiotropium bromide) Inhalation Spray for the Maintenance Treatment of COPD. Sep 25, 2014 1842
Germany : Boehringer Ingelheim and CureVac announce collaboration to develop next generation lung cancer immunotherap. Sep 19, 2014 417
Boehringer Ingelheim and CureVac announce collaboration to develop next generation lung cancer immunotherapy. Sep 18, 2014 3005
Oxford Finance Closes $20 Million Debt Facility with Pulmonx. Sep 17, 2014 416
United Kingdom : GSK data presented at ERS demonstrate potential of blood eosinophil levels to help inform COPD treatment decisions. Sep 9, 2014 259
New Phase III Study Shows Investigational Tiotropium Improves Lung Function in Adolescent Patients with Symptomatic Asthma. Sep 8, 2014 2153
Boehringer Ingelheim Presents Pivotal Phase III Data for the Investigational Fixed-Dose Combination of Tiotropium + Olodaterol in COPD. Sep 8, 2014 1749
Japan : Ant-cancer agent Alecensa capsules introduced by Chugai Pharma. Sep 8, 2014 380
Switzerland : Novartis to unveil new data from three key clinical trials at European Respiratory Society International Congress 2014. Sep 3, 2014 298
Germany : Boehringer Ingelheim to present comprehensive data supporting broad respiratory portfolio in COPD, asthma and IPF at ERS 2014. Sep 2, 2014 298
Ekos nabs FDA OK for its pulmonary embolism treatment device. Sep 1, 2014 323
United Kingdom : GSK receives FDA approval for Arnuity Ellipta (fluticasone furoate) in the USA for the treatment of asthma. Aug 22, 2014 304
Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms. Aug 21, 2014 679
GSK receives FDA approval for Arnuity(TM) Ellipta (fluticasone furoate) in the US for the treatment of asthma. Aug 20, 2014 924
Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD. Aug 19, 2014 2156
FDA Advisory Committee Recommends Approval of Tiotropium Respimat for the Maintenance Treatment of COPD. Aug 14, 2014 1485
Genoa Pharmaceuticals Receives Orphan-Drug Designation for Pirfenidone in the Inhaled Treatment of Idiopathic Pulmonary Fibrosis (IPF). Aug 5, 2014 594
Genoa Pharmaceuticals Receives Orphan-Drug Designation for Pirfenidone in the Inhaled Treatment of Idiopathic Pulmonary Fibrosis (IPF). Aug 5, 2014 599
Concordia Healthcare Corp. initiates Phase 3 bile duct cancer trial using photodynamic therapy with PHOTOFRIN[R]. Aug 5, 2014 1189
Long-term Non-invasive Positive Pressure Ventilation Treatment Delivers 76 Percent Reduction in Risk of Death at One Year among Stable COPD Patients. Clinical report Aug 4, 2014 908
Long-term Non-invasive Positive Pressure Ventilation Treatment Delivers 76 Percent Reduction in Risk of Death at One Year among Stable COPD Patients. Clinical report Aug 4, 2014 915
FDA Approves Boehringer Ingelheim's Striverdi Respimat (olodaterol) Inhalation Spray for Maintenance Treatment of COPD. Aug 1, 2014 1508
Drugs for Lung Disease Work With Body Clock. Jul 28, 2014 480
Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma. Jul 24, 2014 679
Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse. Jul 23, 2014 726
United Kingdom : Intertek co-author study on inhaled medicine test procedures. Report Jul 22, 2014 331
Children's growth 'being stunted by asthma inhalers'. Jul 18, 2014 288
Asthma Inhalers Can Stunt Child Growth. Jul 18, 2014 363
New genes identified to help in asthma treatment. Jul 9, 2014 289
United Kingdom,United States : Anoro Ellipta (umeclidinium/vilanterol) gains approval in Japan for the treatment of COPD. Jul 7, 2014 446
Japan,United Kingdom : Anoro Ellipta(umeclidinium/vilanterol) gains approval in Japan for the treatment of COPD. Jul 4, 2014 436
United Kingdom : GSK and Theravance announce submission to US regulatory authorities for fluticasone furoate/vilanterol in asthma. Jul 1, 2014 324
Bellerophon Therapeutics Completes Enrollment of its Phase 2 Trial of INOpulse For Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease (PH-COPD). Jun 26, 2014 807
Pulmonary Drug Delivery Systems Market (Products - Metered Dose Inhalers, Dry Powder Inhalers and Nebulizers; Applications - Asthma, COPD and Cystic Fibrosis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019. Jun 23, 2014 2089
Emerging Therapies for Previously Treated EGFR Wild-Type/Untested Non-Small-Cell Lung Cancer are Expected to Offer Efficacy Benefits Over Current Treatments. Jun 19, 2014 656
Asmacure Announces Top-Line Clinical Results for ASM-024 DPI in Ph 1/2a Trial. Financial report Jun 18, 2014 1192
Hunterdon Regional Cancer Center: The Only Cancer Center in New Jersey to Offer Immuno-Therapy Clinical Trial for Lung Cancer. Jun 11, 2014 743
DelMar Pharmaceuticals, Inc. Presentation Now Available for On-Demand viewing at RetailInvestorConferences.com. Jun 9, 2014 689
Yoga may not be of much help to asthma sufferers. Jun 3, 2014 197
Parion Sciences Announces Senior Leadership and Organizational Changes. Jun 2, 2014 814
Fears for kids over asthma inhalers. Jun 1, 2014 185
AADI SIGNS LICENSING AGREEMENT WITH CELGENE. Jun 1, 2014 412
Drugs approved in 2013. Briggs, Gerald G. Jun 1, 2014 1467
Safinamide New Drug Application (NDA) Submitted to the US Food and Drug Administration (FDA). May 29, 2014 1548
Xencor Initiates Phase 1 Study of XmAb7195 for Asthma. May 28, 2014 751
Immune Design's GLAAS(TM) Discovery Platform Used in MEDI7510 Phase 1 Trial for Respiratory Syncytial Virus. May 27, 2014 631
New Potential Antibody Treatment for Asthma Discovered. May 23, 2014 445
DelMar Pharmaceuticals to Present at the Third Annual Marcum LLP MicroCap Conference. Conference news May 22, 2014 781
Singapore : ASLAN PHARMACEUTICALS obtains global license to develop Asthma Treatment. May 22, 2014 213
Potential asthma treatment discovered. May 21, 2014 342
Boehringer Ingelheim Presents First Phase 3 Data on Fixed-Dose Combination of Tiotropium Plus Olodaterol in COPD. May 21, 2014 1480
AADi Announces Licensing Agreement with Celgene for Nanotechnology-Based Drug Candidate. May 20, 2014 684
The New England Journal Of Medicine Publishes Positive Proof-Of-Concept Data For New Asthma Treatment. Clinical report May 20, 2014 2113
Vitamin D has limited benefits in asthma treatment. May 19, 2014 404
Leading Pulmonologists Draw National Media Focus to Endobronchial Coil Treatment for Severe Emphysema. May 19, 2014 1028
Ataluren Phase 3 Trial Results in Nonsense Mutation Cystic Fibrosis Published in The Lancet Respiratory Medicine. May 16, 2014 1724
Prosonix to Present Results of Phase 2 Clinical Study of PSX1002 in Chronic Obstructive Pulmonary Disease (COPD) at the American Thoracic Society Meeting. Clinical report May 15, 2014 1010
Prosonix to Present Results of Phase 2 Clinical Study of PSX1002 in Chronic Obstructive Pulmonary Disease (COPD) at the American Thoracic Society Meeting. Clinical report May 15, 2014 1006
DelMar Pharmaceuticals to Present Interim Clinical Data for Ongoing VAL-083 Glioblastoma Multiforme Trial at ASCO. May 14, 2014 563
FLUIDDA'S Technology Assists in Optimizing Treatment for COPD Patients. May 9, 2014 270
FLUIDDA'S Technology Assists in Optimizing Treatment for COPD Patients. May 9, 2014 274
United Kingdom : Anoro (umeclidinium/vilanterol) gains marketing authorisation in Europe for the treatment of COPD. May 9, 2014 348
Study Shows No Benefit From Active Ingredient In Common Cold Medicine. May 8, 2014 540
United Kingdom : GSK receives approval for Incruse Ellipta (umeclidinium) in the US for the treatment of COPD. May 2, 2014 334
Parion Sciences Reacquires Rights to Epithelial Sodium Channel Inhibitors. Apr 30, 2014 508
GSK receives approval for Incruse(TM) Ellipta (umeclidinium) in the US for the treatment of COPD. Apr 30, 2014 1162
United Kingdom : GSK receives EU marketing authorisation for Incruse (umeclidinium) for the treatment of COPD. Apr 29, 2014 452
Anoro(TM) Ellipta now available in the US for treatment of COPD. Apr 28, 2014 2169
Erdosteine Received Orphan Drug Status by the FDA. Apr 28, 2014 1006
Greater Reductions in Exacerbations Remains an Open Area of Opportunity in the Chronic Obstructive Pulmonary Disease Market. Apr 24, 2014 691
Genoa Pharmaceuticals and McMaster University demonstrate inhaled pharmacokinetics enables improved pirfenidone activity with significant promise to enhance IPF treatment safety and tolerability. Apr 21, 2014 627
COPD Drug Market Opportunity and Clinical Pipeline Analysis. Apr 19, 2014 1284
COPD Drug Market Opportunity and Clinical Pipeline Analysis. Apr 19, 2014 1289
United Kingdom : GSK announces approval in Canada for Incruse Ellipta (umeclidinium) as a treatment for COPD. Apr 18, 2014 298
Cough medicine'put driver over drink limit'. Apr 11, 2014 148
United Kingdom : VALIRX partners with TANGENT REPROFILING to advance treatment for lung cancer. Apr 8, 2014 181
DelMar Pharmaceuticals Presents Promising Pre-clinical Data with VAL-083 in Lung Cancer. Apr 7, 2014 1263
DelMar Pharmaceuticals to Present Two Abstracts at American Association of Cancer Research (AACR) Annual Meeting. Apr 2, 2014 714
Nasal spray delivers new type of depression treatment. Mar 24, 2014 645
RCPE to organize symposium on 'Respiratory Medicine'. Mar 19, 2014 282
Specialised Therapeutics Australia Receives Therapeutic Goods Administration Approval for Abraxane(R) in Combination with Gemcitabine for First-line Treatment of Metastatic Pancreatic Cancer. Mar 18, 2014 2028
Landmark Year in Sleep: Leader in Sleep and Respiratory Medicine Highlights Top Five Sleep Apnea Research Findings. Mar 14, 2014 1022
Landmark Year in Sleep: Leader in Sleep and Respiratory Medicine Highlights Top Five Sleep Apnea Research Findings. Mar 14, 2014 1027
Pulmonary Drug Delivery Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019. Industry overview Mar 7, 2014 633
Pulmonary Drug Delivery Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019. Industry overview Mar 7, 2014 681
Alexza Announces the U.S. Commercial Launch of ADASUVE by Teva Pharmaceuticals. Mar 3, 2014 2456
Boehringer Ingelheim Presents Phase 3 Data for Tiotropium Across Asthma Severities. Mar 1, 2014 2762
Phenotypes may increase targeted pulmonary therapies. Mcknight, Whitney Mar 1, 2014 912
ONY Inc., A Pioneer In Neonatal Pharmaceutical Development, Has Entered Into A Co-Promotion Agreement With Recordati Rare Diseases For NeoProfen. Feb 26, 2014 1912
Pulmonary Drug Delivery Systems Market Expected to Reach USD 28.7 Billion Globally in 2019: Transparency Market Research. Feb 25, 2014 1441
Pulmonary Drug Delivery Systems Market Expected to Reach USD 28.7 Billion Globally in 2019: Transparency Market Research. Feb 25, 2014 1461
United Kingdom : GSK receives positive CHMP opinion for Incruse (umeclidinium) for the treatment of COPD. Feb 21, 2014 264
United Kingdom : Anoro (umeclidinium / vilanterol) receives positive opinion from the CHMP in Europe for the treatment of COPD. Feb 21, 2014 340
Passive smoking dangerous for asthmatic kids. Feb 17, 2014 209
Kids exposed to passive smoke respond less to asthma treatment. Feb 16, 2014 173
Clinical Trial Shows eNT Inhaler Produces Rapid and Significant Reductions in Smoking Urge. Feb 14, 2014 887
StemGenex Announces Newest Stem Cell Treatment for COPD Patients. Feb 11, 2014 469
France : SKYEPHARMA intros flutiform asthma treatment in FRANCE. Feb 11, 2014 149
AIT's Phase II Clinical Trial for Cystic Fibrosis Adds Schneider Children's Medical Center of Israel as Second Site in Expanded Trial. Feb 10, 2014 748
Prosonix Reports Positive Top-line Results from its Phase 2 Clinical Study with PSX1002 in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD). Clinical report Jan 23, 2014 1189
Prosonix Reports Positive Top-line Results from its Phase 2 Clinical Study with PSX1002 in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD). Clinical report Jan 23, 2014 1193
Chiesi respiratory r&d project. Jan 21, 2014 245
Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations. Jan 14, 2014 1121
AIT Announces Phase II Study of NOxCureCF, a Respiratory Treatment for Cystic Fibrosis Patients Using a Nitric Oxide-Base Formulation. Report Jan 7, 2014 854
Drug Device Combination Products Market is Expected to Reach USD 115.1 Billion Globally in 2019: Transparency Market Research. Dec 24, 2013 1214
Drug Device Combination Products Market is Expected to Reach USD 115.1 Billion Globally in 2019: Transparency Market Research. Dec 24, 2013 1234
United Kingdom : ANORO ELLIPTA approved as first once-daily dual bronchodilator for the treatment of COPD in the US. Dec 19, 2013 446
FLUIDDA Presents Novel Imaging Technology for Respiratory Diseases to FDA. Dec 18, 2013 479
Hovione: New Inhalation Capsule Filling Machine Fills Market Gap. Dec 5, 2013 520
Dr. Yamo Deniz to Join Cytos Biotechnology's Board of Directors. Dec 4, 2013 1040
Initial Data from Lightlake Therapeutics Joint Clinical Trial with NIDA Shows Nasal Delivery of Naloxone for Opioid Overdose as a Promising Treatment. Dec 3, 2013 822
Racial and ethnic differences in childhood asthma treatment in the United States. Sarpong, Eric M.; Miller, G. Edward Dec 1, 2013 9224
Paediatric spirometry guideline of the South African Thoracic Society: Part 1. Masekela, R.; Gray, D.; Verwey, C.; Halkas, A.; Jeena, P.M. Report Dec 1, 2013 5018
United Kingdom : Cough and cold medicines recalled by Boots UK. Nov 28, 2013 278
Boots recalls kids cough medicines. Nov 27, 2013 102
Boots recalls cough medicine; NEWS IN BRIEF. Nov 27, 2013 119
United Kingdom : RELVARA ELLIPTAA receives European marketing authorisation for the treatment of asthma and COPD. Nov 19, 2013 102
Germany : Boehringer Ingelheim submits applications in Europe to extend the indication for the use of tiotropium RespimatA to the treatment of asthma in adults aged 18 years and over. Disease/Disorder overview Nov 14, 2013 406
Palatin Technologies Announces Issuance of Two Natriuretic Peptide Receptor-Specific Mimetic Patents. Nov 12, 2013 700
Pulmonary hemorrhage with capillaritis secondary to mycophenolate mofetil in a heart-transplant patient. Gorgan, Maria; Bockorny, Bruno; Lawlor, Michael; Volpe, John; Fiel-Gan, Mary Report Nov 1, 2013 2553
Asthma triggers: Pets and plants. Oct 31, 2013 435
BREO ELLIPTA(TM) now available in the U.S. for the treatment of COPD. Oct 30, 2013 2172
AIIMS researchers prove yoga's benefits for COPD patients. Oct 29, 2013 252
Milestone Pharmaceuticals Initiates a Phase 1 Clinical Trial with MSP-2017. Oct 28, 2013 433
New Data Provides Further Evidence of Lung Function Improvements in Severe Asthma with Tiotropium Delivered via the Respimat Inhaler. Oct 28, 2013 1783
United States : GSK submits NDA for asthma treatment. Oct 28, 2013 158
KaloBios Elects Laurie Smaldone Alsup, M.D. to Board. Oct 23, 2013 1120
Germany : New once-daily Striverdi (olodaterol) Respimat gains approval in first EU countries. Oct 19, 2013 413
Celtaxsys Initiates First Clinical Trial of Oral CTX-4430 Therapy in Cystic Fibrosis Patients. Oct 10, 2013 531
IceCure Enters a New High-Potential Market: The company received $100K-order for cryoablation consoles and probes to be used in a clinical study for the treatment of lung cancer. Clinical report Oct 1, 2013 728
Principles of pulmonary medicine, 6th ed. (online access included). Brief article Oct 1, 2013 150
Paid COPD Clinical Trial Now Enrolling at Avail Clinical Research Near Orlando, Florida; Accepting M/F Patients with COPD Age 40+. Sep 29, 2013 690
Successive supply of various parenteral and inhaled medications . Sep 27, 2013 200
United Kingdom : RELVAR ELLIPTA gains approval in Japan for the treatment of asthma. Sep 21, 2013 422
United Kingdom : RELVAR ELLIPTA receives positive opinion from the CHMP in Europe for the treatment of asthma and COPD. Sep 20, 2013 115
New Elekta Radiation Therapy Technology Takes Weeks Off of Lung Cancer Treatments. Sep 19, 2013 648
Lyrica[R] (pregabalin) capsules[v]. Sep 15, 2013 6182
Hovione: EPO Grants a New Inhaler Patent. Sep 11, 2013 565
Data for Investigational Tiotropium Show Improved Lung Function and Sustained Bronchodilation in Patients with Moderate Asthma Severity. Sep 10, 2013 2226
Landmark TIOSPIR(TM) Trial Further Reinforces Safety and Efficacy Profile of Spiriva Respimat in the Treatment of COPD. Sep 8, 2013 2261
Landmark TIOSPIR(TM) trial demonstrates comparable long-term safety of tiotropium delivered via Respimat and HandiHaler in COPD patients. Sep 8, 2013 1999
Olodaterol Shows Sustained Improvements in Lung Function in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD). Sep 8, 2013 2574
Verifying the role of surgical pathologists in the precision medicine of lung cancer. Cagle, Philip T.; Olsen, Randall J. Editorial Sep 1, 2013 2991
Lung cancer biomarkers: present status and future developments. Cagle, Philip T.; Allen, Timothy Craig; Olsen, Randall J. Report Sep 1, 2013 8804
Cardiovascular and respiratory generic medicines. Aug 31, 2013 144
Final Patient Completes Prosonix' Phase 2 Clinical Study with PSX1002 in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD). Clinical report Aug 16, 2013 1042
Final Patient Completes Prosonix' Phase 2 Clinical Study with PSX1002 in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD). Clinical report Aug 16, 2013 1046
Understanding respiratory medicine; a problem-oriented approach. (reprint, 2006). Book review Aug 1, 2013 110
The impact of pulmonary tuberculosis treatment on the prevalence of allergic rhinitis. Lin, Carren Teh Sui; Krishnan, Gopala; Manuel, Anura Michelle Aug 1, 2013 2611
First in Class Once-Daily Dual Bronchodilator Ultibro Breezhaler (QVA149) Gains Positive CHMP Opinion for the Treatment of COPD. Jul 27, 2013 2801
Doctors to join study into treatment of lung cancer. Jul 19, 2013 478
Soon, nasal spray that could put an end to painful dentist injections. Jul 5, 2013 167
Gene clues show which children will grow out of asthma. Jul 5, 2013 322
Housemaid in Dubai arrested for giving baby cough medicine. Jun 29, 2013 579
Cough suppressant may ease fibromyalgia pain. Jun 20, 2013 449
Inspiro Medical Ltd. Completes a Successful First Clinical Trial in Asthmatic Children. Jun 6, 2013 452
Genoa Pharmaceuticals and McMaster University demonstrate in vivo benefit of inhaled pirfenidone offering greater pulmonary fibrosis efficacy than oral therapy. Jun 5, 2013 665
EGEN, Inc. Advances a Systemically Delivered RNAi Therapeutic for the Treatment of Pulmonary Arterial Hypertension (PAH). Jun 5, 2013 888
Tunitas Therapeutics Awarded Phase II SBIR Grant to Advance Asthma Program. Jun 4, 2013 544
DelMar Pharmaceuticals to Present Clinical Trials Data for VAL-083 Brain Cancer Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting. May 28, 2013 604
Record Donation of Respiratory Medicines Headed to U.S. Clinics. May 28, 2013 872
Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD). May 22, 2013 929
Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD). May 22, 2013 933
Phase III Results: Once-daily Tiotropium* Effective in Symptomatic Asthma Patients Irrespective of Their Age, Allergic Status, Smoking Status and Bronchodilator Response. May 21, 2013 2478
Asmacure Highlights Four Presentations on Novel Pulmonary Development Compound ASM-024 Presented at American Thoracic Society 2013 International Conference. Conference news May 20, 2013 1262
France : Stallergenes and DBV Technologies enter into partnership for the development of innovative treatment of respiratory allergies. May 17, 2013 208
Asmacure to Present Four Posters on Novel Pulmonary Development Compound ASM-024 at American Thoracic Society 2013 International Conference. Conference news May 16, 2013 773
United States : FDA cleared requests of THERAVANCE & GSK for COPD Medicine. May 13, 2013 312
United Kingdom : BREO ELLIPTA gains US approval for the treatment of COPD. May 11, 2013 333
BREO(TM) ELLIPTA(TM) gains US approval for the treatment of COPD. May 10, 2013 2185
Asthma treatment cannot be cure but allows patient to live normally. May 8, 2013 719
Asthma treatment can not be the cure but allows patient to live normally. May 7, 2013 728
Warfarin replacements: good for patients, challenging for laboratories. Eby, Charles S. Editorial May 1, 2013 1844
ResMed Noninvasive Ventilation Device Cleared by FDA for COPD Treatment. Apr 25, 2013 834
Switzerland : Novartis once-daily QVA149 shows superior efficacy in reducing exacerbations, improving lung function and quality of life in COPD patients. Apr 24, 2013 405
Cancer Experts Detail Advanced Radiosurgery Treatments for Lung Cancer Using Varian Medical Systems Technologies. Apr 22, 2013 869
United Kingdom,United States : FDA Advisory Committee recommends approval of BREO(TM) ELLIPTA(TM) for the treatment of COPD. Apr 18, 2013 463
FDA Advisory Committee recommends approval of BREO(TM) ELLIPTA(TM) for the treatment of COPD. Apr 17, 2013 1676
'Make new lung drug available' HEALTH. Apr 16, 2013 151
Asmacure Dosed First Subjects With ASM-024 Dry Powder For Inhalation. Apr 15, 2013 868
VERONA PHARMA PLC - Final Results. Company overview Apr 10, 2013 5431
DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting. Apr 1, 2013 586
Nelson Mandela 'Responding' to Treatment for Lung Infection. Mar 29, 2013 312
Exposure to Inhaled Agents at Work Means 1 in 4 of Operated Chronic Sinusitis Patients Fail to Recover. Mar 21, 2013 800
VERONA PHARMA PLC - RPL554 demonstrates airway anti-inflammatory activity. Mar 5, 2013 1330
Acute asthma treatment guidelines: reducing morbidity and mortality in South Africa. Zar, H.J.; Lalloo, U.G. Mar 1, 2013 2025
KaloBios Presents Clinical Results with Anti-GM-CSF Antibody in Persistent Asthma. Feb 26, 2013 1402

Terms of use | Copyright © 2015 Farlex, Inc. | Feedback | For webmasters